Insights

Dr Caldera, from the University of Wisconsin, discusses the safety of COVID-19 immunization for patients with IBD, and how to work with these patients to ensure they receive all the vaccinations they need.

Dr Regueiro and Dr Huang, from the Cleveland Clinic, discuss the development of a novel disease model to identify targets for future ulcerative colitis therapeutic agents.

Dr Cohen, director of the IBD Center at the University of Chicago, recaps his presentation at the Crohn's & Colitis Congress 2021 on using novel small molecule agents to treat inflammatory bowel disease.

In this video, Dr Hanauer, from the Feinberg School of Medicine at Northwestern University in Chicago, reviews his presentation at the Crohn's & Colitis Congress 2021 on "evolutionary" agents on the horizon for treatment of inflammatory bowel...

In this video, Dr Abreu, director of the Crohn's and Colitis Center at the University of Miami Miller School of Medicine, previews her talk for the Crohn's & Colitis Congress 2021 on how basic research is being translated to advances in...

Dr Brenner discusses her presentation at the Crohn's & Colitis Congress on what data indicate about the risks and disease course of pediatric patients with inflammatory bowel disease during the COVID-19 pandemic.

Marla Dubinsky, MD, and Asher Kornbluth, MD, both from the Icahn School of Medicine at Mount Sinai in New York City, discuss the latest updates on COVID-19 vaccines, recent recommendations from the International Organization of Inflammatory...

Dr Feuerstein chaired the guideline panel that developed the American Gastroenterological Association's new guidelines on managing ulcerative colitis. He sat down with Gastroenterology Learning Network to answer a few questions.

Dr Long, professor of medicine at the University of North Carolina at Chapel Hill, discusses her presentation at the Advances in Inflammatory Bowel Disease 2020 virtual meeting on how data from both clinical trials and real-world practice...